In the originally published version of this manuscript, the following disclosures were inadvertently omitted. Carlos L. Arteaga, co-author in this manuscript, receives or has received research grants from Pfizer, Lilly and Takeda; holds minor stock options in Provista; serves or has served in an advisory role to Novartis, Merck, Lilly, Daiichi Sankyo, Taiho Oncology, OrigiMed, Puma Biotechnology, Immunomedics, AstraZeneca, Arvinas, and Sanofi; and reports scientific advisory board remuneration from the Susan G. Komen Foundation. None of these relationships are of any relevance to the work published in this manuscript. These details have been corrected only in this corrigendum to preserve the published version of record. © 2021 Oxford University Press. All rights reserved.